EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 32 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,025,047 | -28.0% | 6,822,114 | 0.0% | 2.06% | -14.5% |
| Q2 2023 | $5,594,133 | +134.3% | 6,822,114 | 0.0% | 2.41% | +171.3% |
| Q1 2023 | $2,387,740 | -18.6% | 6,822,114 | 0.0% | 0.89% | -17.0% |
| Q4 2022 | $2,933,509 | -24.6% | 6,822,114 | 0.0% | 1.07% | -39.8% |
| Q3 2022 | $3,889,000 | -59.9% | 6,822,114 | 0.0% | 1.78% | -62.5% |
| Q2 2022 | $9,687,000 | -64.6% | 6,822,114 | 0.0% | 4.74% | -66.1% |
| Q1 2022 | $27,357,000 | -51.6% | 6,822,114 | 0.0% | 14.00% | -56.1% |
| Q4 2021 | $56,487,000 | – | 6,822,114 | – | 31.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,822,114 | $9,687,000 | 4.74% |
| Abingworth LLP | 4,822,114 | $6,462,000 | 2.07% |
| OUP Management Co., LLC | 1,025,697 | $1,456,000 | 2.00% |
| Column Group LLC | 4,309,329 | $6,119,000 | 1.30% |
| Evolution Capital Management LLC | 527,885 | $750,000 | 1.12% |
| SECTORAL ASSET MANAGEMENT INC | 2,382,644 | $3,383,000 | 0.68% |
| Parallel Advisors, LLC | 1,693,559 | $2,405,000 | 0.11% |
| RESOLUTE FINANCIAL, LLC | 30,000 | $43,000 | 0.04% |
| Oasis Management Co Ltd. | 100,000 | $142,000 | 0.02% |
| Blackstone Inc. | 1,308,587 | $1,858,000 | 0.01% |